{
    "pmcid": "10844482",
    "qa_pairs": {
        "What are nanobodies derived from and what is their structural characteristic?": [
            "Nanobodies are derived from heavy chain antibodies found in camelids and consist of a single variable domain (VHH).",
            "Nanobodies are derived from light chain antibodies found in rodents and consist of two variable domains.",
            "Nanobodies are derived from full-length antibodies found in humans and consist of a constant region.",
            "Nanobodies are derived from single-chain antibodies found in birds and consist of a dual variable domain."
        ],
        "What is a common strategy used to extend the half-life of nanobodies?": [
            "Conjugation to serum albumin or human IgG Fc regions is used to extend the half-life of nanobodies.",
            "Conjugation to polyethylene glycol (PEG) is used to extend the half-life of nanobodies.",
            "Conjugation to liposomes is used to extend the half-life of nanobodies.",
            "Conjugation to gold nanoparticles is used to extend the half-life of nanobodies."
        ],
        "What is a key factor in designing effective SARS-CoV-2 nanobody binders?": [
            "A key factor is the use of recombinant spike proteins for immunization due to their high immunogenicity.",
            "A key factor is the use of whole virus particles for immunization due to their broad antigenic profile.",
            "A key factor is the use of viral RNA for immunization due to its ability to mimic natural infection.",
            "A key factor is the use of inactivated virus for immunization due to its safety and stability."
        ],
        "What is a major challenge in the therapeutic application of nanobodies due to their small size?": [
            "A major challenge is their short half-life, which requires strategies to extend their circulation time.",
            "A major challenge is their high immunogenicity, which requires strategies to reduce immune response.",
            "A major challenge is their low binding affinity, which requires strategies to enhance interaction with antigens.",
            "A major challenge is their poor solubility, which requires strategies to improve dissolution in biological fluids."
        ],
        "What technique is crucial for selecting nanobodies with high specificity and affinity?": [
            "Phage display is crucial for selecting nanobodies with high specificity and affinity.",
            "CRISPR-Cas9 is crucial for selecting nanobodies with high specificity and affinity.",
            "ELISA is crucial for selecting nanobodies with high specificity and affinity.",
            "Western blotting is crucial for selecting nanobodies with high specificity and affinity."
        ]
    }
}